Safety of Enoxaparin during Pregnancy

Meital Shlomo; Rafael Gorodischer; Gideon Koren; Arnon Wiznitzer; Ilan Matok; Amalia Levy

doi:https://doi.org/10.1002/bdra.23258

Safety of Enoxaparin during Pregnancy

Meital Shlomo, Rafael Gorodischer, Gideon Koren, Arnon Wiznitzer, Ilan Matok, Amalia Levy

Research output: Contribution to journal › Meeting Abstract › peer-review

Abstract

As pregnancy is a hypercoaguable state, the risk for thromboembolic event rises. With thromboembolism being the leading cause of death among pregnant women in developed countries, anticoagulation therapy is needed more commonly. Warfarin teratogenicity and heparin's safety profile have placed enoxaparin as the drug of choice for anticoagulation therapy during pregnancy. While several studies investigated enoxaparin effectiveness during gestation, its fetal safety has been only sparsely studied. The aim of this study was to evaluate fetal safety after enoxaparin exposure during pregnancy.

Original language	English
Pages (from-to)	526-527
Number of pages	2
Journal	Birth Defects Research Part A Clinical and Molecular Teratology
Volume	100
DOIs	https://doi.org/10.1002/bdra.23258
State	Published - 1 Jul 2014

Access to Document

https://doi.org/10.1002/bdra.23258

Cite this

@article{5563c83335dc415eb8efb23233b10ec5,

title = "Safety of Enoxaparin during Pregnancy",

abstract = "As pregnancy is a hypercoaguable state, the risk for thromboembolic event rises. With thromboembolism being the leading cause of death among pregnant women in developed countries, anticoagulation therapy is needed more commonly. Warfarin teratogenicity and heparin's safety profile have placed enoxaparin as the drug of choice for anticoagulation therapy during pregnancy. While several studies investigated enoxaparin effectiveness during gestation, its fetal safety has been only sparsely studied. The aim of this study was to evaluate fetal safety after enoxaparin exposure during pregnancy.",

author = "Meital Shlomo and Rafael Gorodischer and Gideon Koren and Arnon Wiznitzer and Ilan Matok and Amalia Levy",

year = "2014",

month = jul,

day = "1",

doi = "https://doi.org/10.1002/bdra.23258",

language = "English",

volume = "100",

pages = "526--527",

journal = "Birth Defects Research Part A - Clinical and Molecular Teratology",

issn = "1542-0752",

publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Safety of Enoxaparin during Pregnancy

AU - Shlomo, Meital

AU - Gorodischer, Rafael

AU - Koren, Gideon

AU - Wiznitzer, Arnon

AU - Matok, Ilan

AU - Levy, Amalia

PY - 2014/7/1

Y1 - 2014/7/1

N2 - As pregnancy is a hypercoaguable state, the risk for thromboembolic event rises. With thromboembolism being the leading cause of death among pregnant women in developed countries, anticoagulation therapy is needed more commonly. Warfarin teratogenicity and heparin's safety profile have placed enoxaparin as the drug of choice for anticoagulation therapy during pregnancy. While several studies investigated enoxaparin effectiveness during gestation, its fetal safety has been only sparsely studied. The aim of this study was to evaluate fetal safety after enoxaparin exposure during pregnancy.

AB - As pregnancy is a hypercoaguable state, the risk for thromboembolic event rises. With thromboembolism being the leading cause of death among pregnant women in developed countries, anticoagulation therapy is needed more commonly. Warfarin teratogenicity and heparin's safety profile have placed enoxaparin as the drug of choice for anticoagulation therapy during pregnancy. While several studies investigated enoxaparin effectiveness during gestation, its fetal safety has been only sparsely studied. The aim of this study was to evaluate fetal safety after enoxaparin exposure during pregnancy.

U2 - https://doi.org/10.1002/bdra.23258

DO - https://doi.org/10.1002/bdra.23258

M3 - Meeting Abstract

SN - 1542-0752

VL - 100

SP - 526

EP - 527

JO - Birth Defects Research Part A - Clinical and Molecular Teratology

JF - Birth Defects Research Part A - Clinical and Molecular Teratology

ER -

Safety of Enoxaparin during Pregnancy

Abstract

Access to Document

Fingerprint

Cite this